Site icon Impactiviti

Impactiviti Daily 090109


Combo pills for high cholesterol: no better than higher doses of single drug? Interesting study results.

Should we really be doing all those PSA tests for prostate cancer? Maybe not.

Shire‘s Gaucher drug on the fast track, due to Genzyme manufacturing problems.

A NY Times interview with Deborah Dunsire, CEO of Millennium – good focus on leadership development.


Managed Care Training. The Impactiviti Partner network is rich with great managed care training providers, from off-the-shelf content to live workshops to consulting expertise to training events.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for information and recommendations!


FDA silence about social media guidance “a problem,” according to a Pfizer exec. Agreed.


Here’s a lightning bolt you definitely would not want to see up-close and personal. Wow!


Subscribe to the Impactiviti blog via e-mail

Connect with Steve Woodruff

Exit mobile version